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Abstract 
Sub-Saharan Africa contains over ten percent of the world's population, almost one-
fourth of the global disease burden, but only three percent of global healthcare workers. These 
problems are exemplified in Kenya. Moi Teaching and Referral Hospital is a national hospital in 
Western Kenya. The catchment area for the sole neurosurgeon at Moi University is estimated 
to contain approximately 20 million people. No research has been published regarding how 
patients reach tertiary care centers in Kenya or how long they have had symptoms prior to 
presentation. Compared with acute disease treated by neurosurgeons, patients with a neuro-
oncologic diagnosis' most often present in clinic. Further, there appears to be no published data 
on access to neuro-oncology care in Kenya, delays in diagnosis possibly lead to more advanced 
stages at the time of diagnosis and potentially worse outcomes. We propose to describe the 
barriers to access of care for patients within this group. We hypothesize that differences will be 
found by age, gender, education level, financial resources, and location of a patient's residence 
in the ability for a patient to have timely access to neurosurgical oncology care in Western 
Kenya. We aim to determine what types of health care providers, if any, patients have seen 
prior to presenting to the neurosurgeon. Assessing the barriers experienced by neuro-oncology 
patients in reaching the only national hospital in Western Kenya will help us design programs to 
intervene and reduce the barriers experienced by patients. 
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Background and Significance 
Introduction 
Sub-Saharan Africa contains over ten percent of the world's population, almost one-
fourth of the global disease burden, but only three percent of global healthcare workers. 1 The 
low number of healthcare professionals and the variable geographical terrain compromises the 
healthcare services available in this region.2 Most people of sub-Saharan Africa live in an 
extreme rural community with fewer resources and further distances to hospitals/clinics than 
rural areas of developed countries, leading to these areas being severely disadvantaged for 
health and survival indicators.3 Those with limited financial resources are even more vulnerable 
as deteriorating infrastructure in addition to unavailable or unaffordable transportation 
decreases the chances for the poor to reach adequate medical facilities. 
Medical care and access to medical care have become headline grabbing topics in the 
national media of the United States. No better example of the type of medical care possible in 
the United States is that of former Senator Kennedy's treatment for a malignant brain tumor.4 
Neuro-oncology care is one of the most highly sophisticated areas of modern medicine. 
Senator Kennedy had the means to search out what he felt was the most advanced care 
available at the Robert Preston Tisch Brain Tumor Center at Duke University Medical Center in 
Durham, NC which is over 700 miles away from Boston and the hospital where he obtained his 
original diagnosis.s Senator Kennedy assembled a team of leading brain tumor experts from all 
over the country, including representatives from Massachusetts General Hospital, the University 
of California- San Francisco, and Duke University to discuss treatment options, in order to 
make the decision to travel from his home in Massachusetts to North Carolina to seek personal 
medical treatment. 5 
Senator Kennedy is an example of an individual with close to unlimited access to the 
best medical care in a developed nation such as the United States of America. But what about 
the access to medical care for individuals without the means of Senator Kennedy? What are 
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the barriers to care for individuals living in poverty or in rural areas in the United States? Are 
the barriers to care different in developing nations such as in sub-Saharan Africa compared with 
nations such as the United States? What are the barriers to care for such complicated medical 
illnesses such as brain tumors? Barriers to care present varying challenges to countries and 
healthcare workers in attempting to provide care to patients while decreasing healthcare 
inequalities. In this paper I will discuss general barriers pertaining to the issue of access to 
health care both within developed and developing countries. This will be followed by a 
discussion of access issues for neuro-oncology care, and will conclude with a proposal for a 
future study to be carried out in Western Kenya to assess the barriers experienced by neuro-
oncology patients there. This proposed study will hopefully help us understand the difficulties 
neuro-oncology patients face in accessing medical care Western Kenya and develop 
interventions and policies to help reduce or remove some of these barriers and increase the 
number of patients able to be treated. 
Access to Care 
The Institute of Medicine defines access to health care as" ... the timely use of personal 
health services to achieve the best possible outcomes"6 Access deals with an individuals' ability 
to find and receive care from a health care system.7 The barriers to medical care access have 
become a very large topic for research and within the medical literature. A PubMed keyword 
search using "barriers to healthcare" or "barriers to medical care" as terms, returns over 16,500 
articles addressing the topic. 
One of the most respected frameworks for assessing access to health care is the 
Anderson Behavior Model. The Anderson Model was developed in the late 1960s as an attempt 
to explain an individual's use of health services 8 The initial model was termed the behavioral 
model and has gone through multiple revisions over the years. The initial behavioral model 
used predisposing characteristics as the first domain -such characteristics as demographics 
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(age, gender), social structure (education, ethnicity, occupation), and health beliefs (attitude, 
values, and knowledge about health and health services). These predisposing characteristics, 
taken with enabling resources- both personal (financial, means of transportation, travel 
distance) and community (health services and healthcare worker availability) - along with health 
need - individuals perceived health care need as well as evaluated need (professional 
judgment) leads to an individuals use of health services. (Figure 1) 
FIGURE 1 (Adapted from ref. 8 [pg. 8]) 
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The first revision added the health care system as a distinct and major component that 
influences access.9 Further revisions added the concept of health status outcome measures, 
and the most recent model utilizes four major categories 1) the environment, 2) population 
characteristics, 3) health behaviors, 4) outcomes, and the importance of reciprocal feedback 
loops which highlight the influence of each of the components on each other8 • 10 Each major 
category has its own subcategories. The environment is measured as an aggregate that utilizes 
the variables of the health system, which takes into account the health organization and 
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provider related issues, and the external environment, or the community composition. 
Population characteristics primarily use the initial behavior model components of predisposing 
characteristics, enabling resources, and need. The outcome component uses an aggregate of 
perceived health outcome, evaluated health outcome, and customer satisfaction. (Figure 2) 
Figure 2 (Adapted fmm ref. 8[p.8]) 
Environment Population Characteristics Health Behavior j- I Outcomes 
The model has been developed for use to assess health care access in the United States and to 
look at overall health; however, it also can be extrapolated and used as a framework in 
assessing access to care for specific diseases and for various populations. I will use the 
Anderson Model framework concentrating on the environment and population characteristics in 
an attempt to understand and assess access to care in this paper. 
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The Environment 
Community composition such as the overall educational level, ethnic composition, 
religion, and employment level can be very important in determining what type of access to care 
an individual will have. For example, in Israel, significant correlations between healthcare 
access with religion, father's ethnicity (Arabic children had shorter lag times than children of 
Jewish parents), and location of residence have been shown.11 
Delivery of healthcare services, such as the presence of hospitals or clinics, the number 
of trained healthcare workers, and the availability of medications can be classified as supply 
barriers. Most supply barriers vary according to the country being evaluated as well as national 
and local governmental priorities. Most health policy is aimed at reducing supply barriers.12 
However, barriers on the demand-side can be just as important in preventing patients from 
accessing medical care. Demand can be influenced from the overall community make-up as 
well as on an individual level and is most appropriately discussed under population 
characteristics. 
Population Characteristics 
Demand barriers have the potential to be even more important than supply barriers for 
poor and underserved groups. This can be due cultural barriers and lack of information can 
prevent them from benefitting from policy changes and public spending.12 Demographic and 
social structure factors such as race, gender, and age are unable to be controlled. Much of the 
literature devoted to assessing individual factors is attempting to identify and remedy disparities 
between groups of individuals such as by race and/or gender. One example is from The Voices 
ofthe Poor cross-country study in Tanzania, which found general agreement that men were 
invariably given preferential access to health care over women. 13 Many poor women have little 
time, money or incentive to access health care.3 A lot of the literature devoted to evaluating 
enabling resources deal with where an individual lives or what finances they have to spend on 
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health care. Living in a rural environment often times limits the supply side by having fewer 
healthcare workers and hospitals but living in a rural area has also been shown to reduce the 
demand.12 The decrease in demand can increase the delay in accessing health care which can 
lead to increased morbidity and mortality. One study in Vietnam found that rural living (distance 
to facilities) is a principle determinant of how long patients delay before seeking care. 14 
Whether it is through supply or demand barriers to medical care, both decrease the likelihood of 
obtaining an evaluation of an illness. Without an evaluation and diagnosis, it is difficult to 
prevent or treat a disease.15 Much research has been done to evaluate how the location of 
where an individual lives affects how healthcare is received. Individuals in rural areas many 
times have fewer medical resources, have to travel long distances to reach healthcare facilities, 
and are more socially isolated. These factors have been found to positively correlate with who 
will not start treatment and/or will drop out of treatment. 16 A study in the US evaluating patients 
after a myocardial infarctions showed that individuals living more than 20 miles away from a 
hospital are much less likely to visit ambulatory services for follow up-care.17 However, it is not 
only rural patients who can have difficulty accessing medical care based on where they live. 
Medical services are frequently inadequate or unavailable within the inner cities in the United 
States.18 
Many authors are interested in how finances affect the type of access to healthcare that 
an individual will have.2 It seems logical to think that individuals with low economic means will 
have less access to medical care compared with individuals such as Senator Kennedy, but that 
is not the only barrier to accessing and receiving healthcare. 
Not only the ill are affected. Many families drift into poverty precipitated by the cost for 
the medical care of the sick, the loss of the family's breadwinner, or the extra expenses incurred 
to take care of a disabled family member. It has been estimated that if medical costs exceeded 
5 per cent of a household's non-food expenditures, families would not be willing, and, in 
consequence, not be able to pay for health care services.19 It is difficult to separate financial 
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means from other potential barriers to care, as economics dictate many factors that have the 
potential to limit access to medical care. There is interest in trying to determine at what 
monetary level finances stop being a barrier to healthcare access. However, it can be difficult to 
indentify accurately who are the indigent and study mechanisms to improve access to health 
care for the indigent.2 
Overview of Health and Healthcare in Sub-Saharan Africa 
The World Health Organization (WHO) has recommended that there should be at least 
10 physicians per 100,000 people; however, many countries in sub-Saharan Africa have most 
districts with less than 2 physicians per 100,000 people.20 Barriers to medical care access as 
well as the inequalities in the burden of disease have recently become prominent concerns for 
many countries in sub-Saharan Africa.7 Countries have begun to institute creative programs in 
attempting to address some of these issues. For instance, in Rwanda the government has 
developed policies and laws for the health system to coordinate donors and external aid, 
monitor the effectiveness of the aid, develop a country-wide independent community health 
insurance program, and begin performance-based pay initiatives.20 However, these programs 
mostly act on the supply side for barriers to healthcare. Demand barriers have the potential to 
vary drastically both within countries and between countries in Sub-Saharan Africa given the 
heterogeneous compositions of the countries, and the fact that demand is influenced by both 
the individual characteristics and health behaviors as delineated in the Anderson Model.8• 12 It 
is difficult to apply much of the work that has been done in developed countries to developing 
nations because of the different challenges faced in the developing world. It is important that 
demand barriers within sub-Saharan Africa are assessed to help develop programs aimed at 
reducing these access issues. 
It is estimated that approximately 12 million people die yearly due to causes that go 
uninvestigated in sub-Saharan Africa. 15 It is unknown how many of these individuals would 
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have survived had fewer barriers to medical access been present. Most of the current data from 
the developing world come from the WHO; however, given the difficulty of obtaining quality data 
in the developing world and the problem of under-reporting, it is likely that the total number 
people experiencing certain diseases, DAL Ys (Disability Adjusted Life Years) lost, and the cost 
burden to developing countries are higher than reported. Effective planning, interventions, and 
decision-making in an attempt to reduce barriers to medical care access should be based on 
evidence, not on guesswork. However, currently no good evidence exists to help policy makers 
make these difficult decisions. Along with policy makers, clinicians become advocates for the 
implementation of barrier reduction strategies as there is no better group to advocate for the 
health of the people than those charged with caring for them. 
Kenya 
These problems are exemplified in the developing sub-Saharan country of Kenya which 
has a population of over 39 million people, over half of whom are between the ages of 15-64.'1 
Kenya is a vast country of over 580 thousand square kilometers from the snows of Mt. Kenya in 
the central region, the semi-dessert terrain in the north, the Indian Ocean to the east, Lake 
Victoria in the west, and the Masai Mara in the south, containing total roadways covering 
177,765 kilometers, 85% of which are unpaved.21 There are 7 provinces and over 60 districts. 
The challenge to reduce healthcare barriers and increase access to medical care is important 
for the population and economy of the country. Improved access to healthcare of adults aged 
15-64 in Kenya is vital to the future economic health of the country, as this age group contains 
the majority of the 16.94 million Kenyan workforce 21 If all of the barriers to healthcare access 
were fully understood the obstacles faced in Kenya would continue to be bountiful and include 
both large and small impediments including limited financial resources, the need for public 
education and development with implementation of programs, and skill development for 
healthcare workers. Bribery and corrupt practicing are often commonplace in developing 
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countries which only add further obstructions to overcome.22 However, we still do not fully 
understand the current barriers that patients face in an attempt to access healthcare and to 
what extent these barriers cause decreased access to medical care. 
Currently, there are two national referral hospitals within Kenya. Kenyatta National 
Hospital primarily serves the capital city of Nairobi and its surrounding area. The second 
hospital is Moi Teaching and Referral Hospital located in the city of Eldoret in the Rift Valley 
Provence23 The hospital serves all of Western Kenya which is more rural and not as developed 
as Nairobi; thus the hospital serves many patients over a larger land area. The poverty 
estimate in the Rift Valley Provence in 2000 was at 47.9%.24 
Neurosurgery and Neuro-oncology in Africa 
Neurosurgery throughout Africa has been improving over the past two decades. It is 
estimated that the continent now has 565 neurosurgeons currently practicing; however, most of 
these surgeons are practicing in the northern countries bordering the Mediterranean Ocean 
such as Morocco and Egypt or in South Africa. This group of countries has over 480 (85%) of 
the continents' neurosurgeons.25 This leaves most of the countries in sub-Saharan Africa with 
less than two or three neurosurgeons to treat their citizens. 
In Kenya, there are a few neurosurgeons practicing within Nairobi; however, only one 
neurosurgeon, Dr. Florentius Koech, serves Western Kenya while working at Moi University 
Teaching and Referral Hospital. Evaluating and addressing barriers to neurosurgical care is 
an important step in improving healthcare quality in Western Kenya as well as aiding in the 
retention of the only neurosurgeon in Western Kenya. Dr. Keech estimates that approximately 
one-third of his clinic patients have presented to him over the past few years with a neuro-
oncologic diagnosis.26 On a recent seven week stay in Kampala, Uganda my experience 
working in a tertiary care referral hospital neurosurgical clinic was similar. 
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A PubMed keyword search combining the terms "neuro-oncology" or "brain neoplasm" 
and "Kenya" returned 7 articles; however, 3 of these were written before 1980, 1 primarily 
concerns testicular cancer, 1 primarily concerns cerebral malaria, and the other 2 articles 
evaluated the number of brain tumors treated in Nairobi. There appears to be no published data 
on access to neuro-oncology care in Kenya and more specifically the less developed Western 
Kenya. Since the 1993 World Bank report "Investing in Health" was published there have been 
multiple programs and plans initiated in sub-Saharan African countries; however, no research 
has been done to learn how patients reach tertiary care centers and how long they have had 
symptoms prior to presentation?· 20 
Study Proposal 
I propose a three phase study to be carried out in Western Kenya to assess the barriers 
experienced by neuro-oncology patients being treated by the sole neurosurgeon at Moi 
University Teaching and Referral Hospital. There is extreme interest of the hospital in 
determining referral patterns for neuro-oncology patients, who they are, and if many patients are 
not finding their way to Moi Teaching and Referral Hospital. The catchment area for the sole 
neurosurgeon within the public health system in Western Kenya is estimated to contain 
approximately 20 million people.26 Based on conversations I have had with Dr. Koech the 
number of patients he sees with advanced neuro-oncologic diagnoses because of the extreme 
length of time it has taken the patient to arrive in his clinic appears to be increasing. It is unclear 
whether the patients have seen a healthcare provider prior to presenting to the tertiary care 
center, and if so, what type of provider or how many providers were seen prior to presenting to 
the neurosurgeon. The time from initial symptoms until presentation to the neurosurgeon is 
greater allowing more potential routes for a patient to navigate within the referral network. 
Delays in evaluation possibly lead to more advanced cancer at the time of diagnosis, a 
12 
potentially worse outcome, and a possible increase in therapy27 Through understanding 
reasons for the delay in reaching the tertiary care center interventions may be developed. 
We will base our study on the Anderson Model discussed earlier. We will also be able to 
describe characteristics of the patients who present to the tertiary care center and whether there 
are groups of people who have even less access than those who were able to navigate the 
barriers and arrive at Moi Teaching and Referral Hospital for care. The study will attempt to 
address the following questions: 
1. What are the perceived barriers to neuro-oncologic access in Western 
Kenya? (Individual Characteristics, Health Needs} 
2. How long does it take for a patient experiencing symptoms related to a 
neuro-oncologic diagnosis to present to a tertiary care facility? (Individual 
Characteristics) 
3. How many healthcare practitioners have patients seen and what 
treatments have been prescribed prior to presenting to a neuro-surgeon 
in Western Kenya? (Environment, Individual Characteristics) 
4. What symptoms are the most common presenting signs for a neuro-
oncologic diagnosis? Is there a difference in the time it takes for patients 
with different symptoms to present initially to a healthcare practitioner and 
subsequently to a neuro-surgeon in Western Kenya? What are the 
perceived health conditions for the common presenting symptoms? 
(Individual Characteristics, Health Needs} 
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5. What is the income level for patients presenting to a neuro-surgeon with a 
neuro-oncologic diagnosis in Western Kenya? (Individual Characteristics) 
6. What is the average amount of money spent on doctors and tests prior to 
a diagnosis of a neuro-oncologic illness? (Environment, Individual 
Characteristics) 
7. How far from a tertiary care center do patients live who present to a 
neuro-surgeon with a neuro-oncologic diagnosis in Western Kenya? 
(Individual Characteristics) 
8. What is the financial cost to travel to the tertiary care center? (Individual 
Characteristics) 
9. What is the sex distribution of patients presenting to a tertiary care center 
with a neuro-oncologic diagnosis? (Individual Characteristics) 
10. What is the education level of patients presenting to a tertiary care center 
with a neuro-oncologic diagnosis? (Individual Characteristics, Health 
Needs) 
Materials and Methods 
This will be a multi-phase study which will be conducted over a one year period. Data 
will be obtained through a questionnaire administered by personal interview. The first phase of 
the study will be to develop a culturally appropriate questionnaire which can be administered by 
native Kiswahili speakers. The survey will contain a combination of prior validated questions as 
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well as new questions designed by the research team. We will use qualitative methods to 
revise the initial survey. The survey will initially be developed in English and subsequently 
translated into Kiswahili (than official language of Kenya). The survey will then be given to 1-2 
focus groups consisting of 5-6 individuals who speak Swahili as their primary language. 
Questions will be revised and reordered as necessary based on focus group feedback. The 
revised survey will be field tested with 10 non neuro-oncology neurosurgery patients. The 
survey will be further revised if necessary. 
The second phase of the study will take place in Kenya. Over a two month period we 
will visit villages in the catchment area for Moi University Teaching and Referral Hospital. In 
these villages focus groups will be held discussing the perceptions and perceived regional 
variations dealing with barriers to access for neurosurgical oncology care as well as allowing us 
to understand the cultural backgrounds for our patients. These focus groups will be recorded 
and analyzed to determine whether there are themes present which are not adequately 
captured in the official personal interview questionnaire. The survey will be revised one last 
time and prepared for administration. 
The final phase of the study will occur over the next 7 months as the questionnaire will 
be offered to every neuro-oncology patient presenting to the neurosurgery clinic at Moi 
University Teaching and Referral Hospital. There will be no incentive offered to the patients 
who participate. The data will be collected during a clinic visit or within 3 months if the patient is 
unable to complete the interview on the initial visit. All neuro-oncologic diagnoses will be 
confirmed by either CT or MRI imaging. All radiographic imaging and neurologic physical 
examinations will be reviewed by the study investigators. The demographic, anthropomorphic, 
and historical data will be used to address the questions surrounding how patients present for 
neuro-oncologic care; however, all of the data, including imaging characteristics, will be used to 
help create a database for use in future epidemiology and outcome based studies. Only the 
native Kiswahili speaking research nurse and research assistants will administer the personal 
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interview questionnaire which will be completed by the participant in a separate interview room 
at their convenience. 
Sample Size and Population 
The target population for the analysis of patients with neuro-oncologic disease includes 
patients in the Neurosurgery clinic at Eldoret. Inclusion criteria: Age at least18 years and a 
confirmed or presumed neuro-oncologic diagnosis. Kenyan patients younger than 18 years are 
more likely to be dependants and thus have the potential to rely more heavily on guardians to 
reach a tertiary care referral center. Enrollment Estimate: It has been estimated that 
approximately 3-5 patients with a new neuro-oncologic diagnosis present to the neurosurgery 
clinic at Moi University Teaching and Referral Hospital per week. Over the course of seven 
months, we expect to enroll at least 75 neuro-oncologic disease patients. 
Recruitment and Consent Process 
Eligible patients will be identified by clinical officers seeing patients in clinic. Patients will 
be referred to the research assistant after check in at the neurosurgery clinic. The research 
assistant will contact the patient in order to obtain consent to participate in the study. Informed 
consent is obtained in Kiswahili using forms at the appropriate reading level. The research 
assistant will be primarily responsible for patient enrollment and consent thereby limiting the 
need for translation. When translation is required, we will utilize Moi University translators and 
nurses who are not part of the patient's primary care team. We will avoid using clinicians who 
have direct responsibility of each person's care to translate in an effort to limit bias and 
coercion. 
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Analysis Plan 
The baseline characteristics of the patient population will be evaluated in a univariate 
analysis and displayed as means and standard deviations for continuous variables and 
prevalence (percentages) for categorical variables. Length of time in days until presentation to 
the neurosurgery clinic at Moi University Teaching and Referral Hospital will be treated as a 
continuous variable. Categorical variables will be the initial healthcare provider seen 
(Traditional Healer, Non-professional Trained Healthcare Worker, Nurse, Physician); number of 
healthcare providers seen prior to presentation to the neurosurgery clinic (0-1, 2-4, >5); age in 
years (18-30, 31-50, >50); gender (male/female); income level (categories will be determined 
after focus groups); education level (did not finish primary school, primary school graduate, 
secondary school graduate, university graduate, doctoral program graduate); distance in 
kilometers from place of residence to Moi University Teaching and Referral Hospital (will 
determine categories after focus groups); cost to travel to Moi University Teaching and Referral 
Hospital (will determine categories after focus groups); primary financial provider for family 
(Yes/No); and the initial presenting symptom is headache (Yes/No), weakness (Yes/No), 
seizure (Yes/No), visual changes (Yes/No), cognitive decline (Yes/No), aphasia (Yes/No), other 
(Yes/No). Bivariate analysis will then be performed comparing length of time to neurosurgical 
oncology care with categorical variables using a student's t-test or AN OVA and using simple 
linear regression for continuous variables. Finally multivariate regression will then be 
performed. 
Limitations and Challenges 
This study is designed to attempt to describe barriers to access for neurosurgical 
oncologic care in Western Kenya. As it is a survey it has inherent limitations related to its 
design. We will only be able to capture a fraction of the patients in Western Kenya who actually 
suffer from neuro-oncologic disease. There will be a portion of patients who have neuro-
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oncologic illness but are never diagnosed either because they never have symptoms or they die 
prior to presentation. There will also be other patients that are never referred or choose not to 
come to the tertiary care center in Western Kenya even if a diagnosis has been established. 
Translating a survey from English to Kiswahili may make some of the questions unclear. We 
are attempting to reduce this risk by having the survey interview guide undergo multiple 
revisions using native Kiswahili speakers as part of the research team. 
Recall bias is inherent when using a questionnaire to obtain data. There is also the 
possibility that the research personnel administering the interview questionnaire can influence 
the answers given by the patients which would influence our results. We will train with our 
research personnel prior to the beginning of the study to make them aware of this potential for 
biasing the answers given. This study is not designed to be able to determine the prevalence of 
neuro-oncologic disease in Western Kenya, but rather is an initial foray into determining the 
characteristics of the patients who are able to maneuver through the healthcare system and 
reach the tertiary care referral hospital as well as the barriers to neuro-oncologic care faced by 
patients in Western Kenya. 
Future Research 
Along with helping to evaluate barriers to access of care for neurosurgical oncology 
patients in Western Kenya, this study will help to develop an initial database of patients. This 
patient database will be used in the future to obtain epidemiologic data for neurosurgical 
oncology patients presenting to Moi University Teaching and Referral Hospital as well as for 
design of further studies to evaluate surgical outcomes for various neuro-oncologic diagnoses. 
This survey will begin a multi-year effort, with this study serving as a foundation, to analyze and 
improve the care neuro-oncologic patients receive in Western Kenya. We hope to develop 
more sophisticated studies evaluating potential genetic or biochemical differences in the 
neoplasms found in neuro-oncologic patients in Western Kenya compared with those found in 
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other regions. We are excited to see where the future will take us both in improving the care 
neuro-oncologic patients receive in Western Kenya and taking what we learn from these 
patients to help patients throughout the world. 
Appendix 1: Possible Sample Questions for Questionnaire (in English) 
Open Ended Questions: (will be coded by investigators by themes) 
1. What are sorne things you can think of that make it hard for people in 
your community to get health care? 
2. What would make it difficult for people in your community to get to a 
neurosurgery clinic? What made it difficult for you to get seen here at 
the neurosurgery clinic? 
3. How rnany days ago did you experience your first symptom? 
4. What treatments have been prescribed for your symptom(s)? 
Multiple Choice Questions 
1. Approximately, how long did you wait before seeing a healthcare 
provider for your symptom? (will determine choices after focus 
groups) 
2. What type of healthcare provider did you first see after you developed 
your first symptom? 
a. Traditional Healer 
b. Non-professional Trained Healthcare Worker 
c. Nurse 
d. Physician 
3. How many healthcare practitioners have you seen since you 
developed your first symptom(s)? 
a. 0-1 
b. 2-4 
c. >5 
4. What was your first symptom that you noticed? 
a. Headache 
b. Weakness 
c. Seizure 
d. Visual Changes 
e. Cognitive Decline 
f. Aphasia 
g. Other 
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5. Have you experienced any of the following symptoms in addition to 
your initial symptom? 
a. Headache (Yes/No) 
b. Weakness (Yes/No) 
c. Seizure (Yes/No) 
d. Visual Changes (Yes/No) 
e. Cognitive Decline [will reword] (Yes/No) 
f. Aphasia (Yes/No) 
g. Other (Yes/No) 
6. How would you classify your financial status? (will determine choices 
after focus groups) 
7. How much money have you spent on doctors and tests after you first 
developed your symptom? (will determine choices after focus groups) 
8. How far do you live from Moi University Teaching and Referral 
Hospital? (will determine choices after focus groups) 
9. How much money did you spend to travel to Moi University Teaching 
and Referral Hospital? (will determine choices after focus groups) 
1 0. What is your sex? 
a. Male 
b. Female 
11. How old are you? 
a. 18-30 years old 
b. 31-50 years old 
c. >50 years old 
12. What school level did you complete? 
a. Did Not Finish Primary School 
b. Primary School Graduate 
c. Secondary School Graduate 
d. University Graduate 
e. Doctoral Program Graduate 
13. Are you the primary financial provider for your family? 
a. Yes 
b. No 
14. What is your ethnicity? (categories will be determined after focus 
groups) 
a. Luo 
b. Kalenjin 
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Appendix 2: Mock Tables 
Table XX: Patient Characteristics (n=75) 
Characteristic 
Length oftime (days) to presentation to Moi University Teaching 
and Referral Hospital from first experiencing first symptom 
Age in years 
(Categories to be determined) 
Male 
Financial Provider of Family 
Distance From Place of Dwelling to Moi University Teaching and 
Referral Hospital (categories to be determined) 
Ethnicity (categories to be determined) 
Luo 
Kalenjin 
Etc. 
Education 
< Primary School 
Primary School 
Secondary School 
University 
Doctoral 
Presenting Symptom 
Headache 
Weakness 
Seizure 
Visual Changes 
Cognitive Decline 
Aphasia 
Other 
Income Level 
(Categories to be determined) 
Cost to Travel to Moi University Teaching and Referral Hospital 
(Categories to be determined) 
Mean (SD) 
or Percent 
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Initial Provider Patients Presented To 
Traditional Healer 
Non-professionally Trained Provider 
Nurse 
Physician 
Table XX: Bivariate Associations Between Patient Characteristics and Days to 
Presentation to Moi University Teaching and Referral Hospital Neurosurgery 
Clinic 
Characteristic 
AQe 
Patient gender 
Male 
Female 
Patient Ethnicity (categories to be 
determined) 
Luo 
Kalenjin 
Financial provider for family 
Yes 
No 
Distance From Place of Dwelling to Moi 
University Teaching and Referral Hospital 
(categories to be determined) 
Education 
< Primary School 
Primary School 
Secondary School 
University 
Doctoral 
Presenting Symptom 
Headache 
Weakness 
Seizure 
Visual Changes 
Cognitive Decline 
Aphasia 
Other 
Income Level 
(Categories to be determined) 
Cost to Travel to Moi University Teaching 
and Referral Hospital 
(CateQories to be determined) 
Initial Provider Patients Presented To 
Traditional Healer 
n 
75 
Days: 
Mean or 
Correlation 
p 
value* 
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Non-professionally Trained Provider 
Nurse 
Physician 
* Means and p values based on 2-sample !-tests or one-way analysis of variance 
for variables with more than two categories; Correlations and p values based 
on Pearson's correlation 
Table XX: Adjusted Comparisons Between Patient Characteristics and Days to 
Presentation to Moi University Teaching and Referral Hospital Neurosurgery 
Clinic (cannot mock up table as it will depend on multiple linear regression model) 
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Appendix 3: Critical Appraisal on Neurosurgery Workforce in the United States and the 
European Union 
As alluded to earlier in this paper the ratio for neurosurgeons to people in Sub-Saharan 
Africa is somewhere between 1:3.6 million and 1 :46 million depending on which country is 
evaluated.25 It is an understatement to state that this ratio is likely too great to provide adequate 
neurosurgical care to the patients living in these areas; however, what is the optimal ratio of 
neurosurgeons to people in a population? This is a difficult question to answer as many factors 
can influence what an appropriate ratio would be. In Japan the ratio is approximately 1:17,000, 
although many would argue that this ratio is artificially inflated as many neurosurgeons in Japan 
are not in clinical practice. Regardless Japan retains the highest ratio of neurosurgeons to 
people in the world.28• 29 Determining what the appropriate neurosurgeon to population ratio 
should be, has been of intense interest over the years both in the United States and the 
European Union; however, most of the literature devoted to this topic is based on expert 
opinion. The United States of America and countries of the European Union represent some of 
the most developed countries in the world and have the potential to be a more homogenous 
sample to help determine what a theoretically appropriate neurosurgeon to population ratio 
should be. A keyword PubMed search using "European Union" or "United States" with MeSH 
search terms "Neurosurgery" and "manpower" returns 42 articles published since 2000. Most of 
these articles address neurosurgical subspecialties (#20), how many neurosurgical residents 
should be trained yearly (#3), are historical reviews of neurosurgery (#6), address gender equity 
in neurosurgical training (#3), legal issues involving neurosurgery (#2), or articles with no 
relevance to the topic (#6). Only 2 articles attempt to address the appropriate neurosurgery 
workforce in the United States of America or the European Union.30• 31 Both of these articles will 
be critically evaluated. 
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Neurosurgical Workforce in the United States 
In the article Neurosurgical workforce trends in the United States by Gottfried et al in 
2005, an analysis of the US neurosurgery workforce is presented by using recruitment 
advertisements published over 10 years as a proxy for determining whether the US has an 
appropriate neurosurgeon to population ratio.30 A critical analysis of their work is presented in 
Table 1. It currently is estimated that in the US there is a neurosurgeon to patient ratio of 
1:62,000.31 The authors conclude in this paper that there has been an increase over the past 
10 years in the number of neurosurgeon recruitment advertisements which argues that the 
current ratio of neurosurgeons to patients is too high based on demand for neurosurgical care in 
the United States and more neurosurgeons are needed. 
Gottfried 0, Rovit R, Popp A, et al. Neurosurgical Workforce 
Trends in the United States. J. Neurosurg. 2005; 102: 202-208 
Study Question: What has the demand been for the 
clinical neurosurgery workforce over the past 10 years? 
Study Secondary Questions: What is the demand for general 
neurosurgery positions compared with neurosurgery 
subspecialty positions? What is the demand for academic 
neurosurgery positions compared with private sector positions? 
Research Design: Retrospective Review of Recruitment 
Advertisements in the 2 US Journals 
Source Population: 240 issues of the Journal of 
Neurosurgery and Neurosurgery from 1994-2003 
Ineligible: Recruitment Advertisements for fellowship, 
research and 
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Initial Comparab.ilityoJ ••... ·.···· 
groups (ie, randqmi:;;:ation · 
or grol!ppom~o§Jt(on; , 
concealmenFotallocation 
Drop ol.lts([\g~l}dpoint \ 
data), adp~f.~llC:~.< <,· ; cros~overs (~t!((W~n. lo~l)tcii;. 
f.ollow.u · ·· ·· · · ·· · 
Measl.lreme!Jfoi expo~~re.;'' 
interv~n(iqll;·~~ie2t,i8,LycT .confou[lp~rs}and iK ct !\. ···. 
ou.tcomes:r~.li~biljty,<l(ld.••··· .. 
validity.Ofll)~a§ur~f11~nt;·•• 
h.ow · erformed,blindin · 
Study Population: 2120 recruitment advertisements within 
the 240 issues of the Journal of Neurosurgery and 
Neurosurgery from 1994-2003. Advertised positions were 
listed as academic or private sector with academic positions 
being defined as one advertised by an institution with an 
Accreditation Council for Graduate Medical Education 
approved neurosurgical residency program. Advertisements 
were also listed as subspecialty positions or general positions. 
Subspecialty positions (pediatrics, spine, vascular, 
endovascular, oncology, stereotactic, functional, epilepsy, pain, 
stereotactic radiosurgery, skull base, trauma) were defines as 
advertisements that specified fellowship training, subspecialty 
ex ertise, or subs ecialt ex erience re uired for em lo men!. 
Non-Randomized 
Not Applicable 
+++ 
Recruitment Advertisements in the two major neurosurgical 
journals only represents a subset of the job positions available. 
Not all positions available are advertised as many positions are 
privately recruited for, use recruitment firms, use recruitment 
mailings, or rely on word of mouth. This would be especially 
true in evaluating the potential for selection bias of the 
secondary questions as it is unknown whether there is a 
difference in the use of these recruitment methods for 
academic compared with private positions or general versus 
subspecialty positions. However, the authors do cite previous 
studies to show the reliability and validity of using recruitment 
advertisements as an index for evaluatin the workforce. 
Equal Measurements of the two journals used. 
Each recruitment advertisement was assigned to the initial 
month and journal it appeared. 
Advertisements that specified two or more positions were 
recorded individually 
Potentialform~.a~l.lrernen\":t ++ 
bias (+.to~+~) •·· ··· · 
No mention of who or how many people evaluated the 
recruitment advertisements 
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The authors tell us there was no change to journal policy; 
however, they do not mention whether there was a change in 
the cost for listing an advertisement or how much space was 
I 
The authors do not tell us how they controlled for 
advertisement cost 
Means and Standard Deviations were obtained for the yearly 
advertisement totals . 
. ··-'''"''·' Comparisons were rnade between the first 5 years and the 
in recruitment advertisements frorn -120 in 1994 to 297 
in 2003 
Academic versus Private Sector Position Advertisements -
private sector advertisements increased from - 80 in 
1994 positions to -160 in 2003, and academic positions 
increased from -45 positions in 1994 to -90 positions in 
2003; thus both private and academic positions 
approximately doubled during the time frarne studied. 
General versus Subspecialty Position Advertisements-
increase in recruitment of general neurosurgery position 
advertisements from 113 in 1994 to 247 in 2003, and 
subspecialty position recruitment advertisement 
number neurosurgeons to treat 
the US population is important to reduce the morbidity and 
mortality caused by diseases treated by neurosurgeons. Many 
neurosurgical illnesses are life threatening if left untreated. 
This study suggests that the increase in neurosurgery position 
advertisements reflects a shortage in the supply of 
'"'"·-' .1 neurosurgeons needed; however, this study does not attempt to address whether the positions advertised become filled or 
remain unfilled. If a large number of positions remain unfilled 
this could have detrimental effects for patients suffering frorn 
I 
Difficult to assess; however, it would only be generalizable if 
recruitment advertisements truly are representative of the 
dernand for 
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Neurosurgeon to patient ratio is an important ratio to help 
determine timely and necessary neurosurgical treatment for 
patients suffering from illnesses seen by neurosurgeons. This 
study raises the question as to whether the current 
neurosurgeon to patient ratio is appropriate as the number of 
neurosurgical positions advertised for has increased over the 
past 10 years. Further work needs to be done to evaluate the 
length to neurosurgical intervention and outcome for 
neurosurgical patients in various regions with different 
neurosurgeon to patient ratios. 
I am concerned that this paper does not adequately address 
this issue alone. Using advertisements is one method for 
potentially evaluating the appropriate neurosurgical workforce, 
but using multiple methods all showing similar results would be 
more convincing and useful in attempting to determine how 
lar e the neurosur ical workforce in the US should be. 
Neurosurgical Workforce in the European Union 
In the article A Report on Neurosurgical Workforce in the Countries of the EU and 
Associated States by Reulen et al in 2009, a report from the European Union of Medical 
Specialists Section of Neurosurgery is presented in an effort to help guide what the appropriate 
ratio for neurosurgeons to patients in the European Union should be. A critical analysis of the 
report is presented in Table 2. The authors of this paper concluded that an appropriate range 
ratio of neurosurgeons to patients should be between 1:60,000- 1 :85,000 to provide adequate 
neurosurgical care to patients in the European Union. 
population ratio in the countries of the European Union? 
Secondary Question: How many neurosurgeons are presently 
being trained in the countries of the European Union? 
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Study Population 
( descriptiyEl: demographics, 
eli gibi(.ity c;rite~~) and ~OV{ 
chOl>!'Jrt()lpl,~ptEl•El.Fl>·••··'·<···· ).•·' rec;ruitfr1e?t•·t§.l'ti~:fYe~re '; , 
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Initial GO[T)parabilityot·•.······· · 
groups ·(ie, .ra[tdqllli:z:~tion 
or 9,f9HH>C:9JRP.().si~iq.n,i / .. i · 
conce~lrijent(jfaiJqc;;Jtiqn) .· 
DropoiJts(RO.erldp?iht•••.• ••.. ·.·.···•·.······ data), adhElrence, .·· .... · · ... , ...••.....• 
crossovers (attritioQ, loss to . 
follow up) 
Study Population: 27 country EUMS Section of Neurosurgery 
Delegates 
There is no mention as to who the EUMS Section of 
Neurosurgery Delegates are or how they became Delegates. 
There is no mention as to whether there is any eligibility criteria 
for becomin a dele ate 
The European Union is a heterogeneous group of countries 
with different political and medical systems in Europe. There is 
no discussion of the group composition which completed the 
surve . 
No mention whether a country/delegate in the European Union 
or Associated States declined to participate or did not return 
the survey. 
Portugal and Greece did not provide information regarding 
number of neurosurgical procedures performed per million 
population or number of neurosurgical procedures each 
erforms er ear. 
There is no discussion as to the make up of the respondents of 
•••...•. ·.·•. r the survey or how the delegates were chosen from each 
country. Within the Evaluation of Data section in the paper it 
·· .•. ·• ... • •••• r states the after the initial data was obtained the report was 
amended and re-sent to the national delegates for a second 
check of the data. This gives the national delegate a chance to 
:·•·•'•><.·::·<'··<'1 change there reported statistics if they do not like where they 
Measurem.E:lntof .. exposure. : 
inteivention,potenti~lii ; .. 
confoundElrs, ancJ.·· .... '.< . ·,· 
o~tcomes; .. rel.i~.bility.'.~ll<:l<. '''·• 
validity ofmE:l~~tJre[T)et1!; • : • · 
ho"'' perfqrmed; oii[ttUf]g . , ... · 
PotentiaTfor.J'l'leasureJ'l'lent 
bias (+to++-t,)·'. 
Potential .. confdullders i 
(nameanddesc;ribe h()~i 
each was contrpiiE(d for)· 
fall in com arisen with other Euro ean Union Member Nations. 
Number of Neurosurgeons to Population 
Number of Neurosurgery Operations per million population 
Average Number of Neurosurgical procedures each 
Neurosurgeon performs per year 
Average number on yearly new neurosurgical trainees 
There is no mention as to how the reported numbers returned 
on the survey are obtained from the various countries. As the 
European Union Member States and Associated States are a 
heterogeneous group, there may be variations in the quality of 
the medical workforce monitorin s stems. 
++ 
Political Motivations 
Cultural Motivations 
These were not controlled for 
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Numbers are on the survey with 
Univariate 
Minimum Ratio for Neurosurgeon to Population: 1:39,800 
(Greece) 
Maximum Ratio for Neurosurgeon to Population: 1 :294,000 
(UK) 
Median Ratio for Neurosurgeon to Population: 1:84,000 
Mean Ratio for Neurosurgeon to Population: 1 :99,152 -
standard deviation of 50,698 
Minimum Number of Neurosurgical Procedures per Million 
Population/Year: 770 (Poland) 
Maximum Number of Neurosurgical Procedures per Million 
Population/Year: 3,600 (Luxemburg) 
Median Number of Neurosurgical Procedures per Million 
Population/Year: 1,500 
Mean Number of Neurosurgical Procedures per Million 
i 1 neurosurgeons to 
the European Union population is important to reduce the 
morbidity and mortality caused by diseases treated by 
neurosurgeons. Many neurosurgical illnesses are life 
,,, , threatening if left untreated. This study suggests that there is 
large variability in the European Union for the neurosurgical 
workforce. However, they conclude that an "optimal" ratio of 
neurosurgeons to population is between 1 :60,000 and 1 :85,000 
with an average workload of 150 operations per neurosurgeon 
I for 
u"'""u"'l to assess; on I generalizable to 
developed countries similar to those in the European Union or 
Associated States 
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Neurosurgeon to patient ratio is an important ratio to help 
determine timely and necessary neurosurgical treatment for 
patients suffering from illnesses seen by neurosurgeons. This 
study also raises the question as to what neurosurgical 
workload is appropriate per neurosurgeon for appropriate 
neurosurgical care of the population. Further work needs to be 
done to evaluate the length to neurosurgical intervention and 
outcome for neurosurgical patients in various regions with 
different neurosurgeon to patient ratios and different 
neurosurgeon workload. 
I am concerned that this paper does not adequately address 
this issue alone. This survey presents data that was obtained 
in 2005/2006 but was not published until 2009. Many changes 
have developed in the time from data collection to publication; 
however, the survey does show the wide variabilily in the ratio 
for neurosurgeons to population and the importance in the 
continued evaluation of the neurosurgical workforce in helping 
to determine what an appropriate or acceptable number of 
neurosur eons er o ulation would be. 
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Conclusion 
It has been almost 50 years since Kerr White presented community illness prevalence 
and the role of physicians and hospitals using nested squares.32 (Figure 3) 
Figure 3 (Adapted from ref. 32 [p. 889]) 
Adult Population At Risk 
Adult Reports~ I illness or 
injury per month 
Adult Consulting a Physician~ I 
time per month 
Adult Patients Admitted to a 
Hospital per month 
Adult Patients Referred to 
Another Physician per month 
Adult Patients Referred to a 
University Referral Hospital per 
month 
Neurosurgeons typically do not see patient's until they are referred to the tertiary care center 
(e.g., University Medical Center), which represents a very small number of the total population 
at risk. Although the United States of America and the countries of the European Union tend to 
be highly developed nations the neurosurgical needs of patients in these countries have the 
potential to vary. One area this seems to be the most evident would be in spine surgery. In the 
US, neurosurgeons are trained during residency to perform spinal decompression and fusion 
surgeries; where as in most European Union countries, spinal surgeries are performed by 
orthopedic surgeons as opposed to neurosurgeons. Peripheral nerve surgery is another area 
where significant overlap could occur with other surgical subspecialties as some orthopedic and 
plastic surgeons also perform these procedures. However, based on these two recent papers 
32 
an argument could be made that in developed countries a goal ratio of neurosurgeons to 
patients could be somewhere in the range of 1:60,000. It is much more difficult to determine 
what an appropriate ratio goal for neurosurgeon to patient ratio should be in developing 
countries as it is difficult to determine what the neurosurgical care need truly is. It is likely not to 
be as low as 1:60,000, but it also is not in the current range of 1:3,600,000-46,000,000. A 
study modeled after Kerr White's nested squares specifically addressing neurosurgical care in 
the developing world would be a helpful aid in determining an appropriate ratio goal. 
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Appendix 4: Proposed Grant Application 
(Based on the official Fogarty Clinical Research Fellowship Grant Application) 
FICRS-F 
Fogarty International Clinical 
Res~arch Scholars & Fellows 
Support Center@ Vanderbilt 
International Clinical Research Fellowship 
APPLICATION- Due 5 Dec. 2009 
Full Name: _,_P_,a,_,rk,e::_r __________ _,S~t,_e"'p'-'"he,n"--------------'-R'-- Date: 10/25/2009 
Last First M.l. 
Address: 
Street Address Apartment/Unit # 
City State ZIP Code 
Phone: E-mail: 
US Citizen/Perm 
SSN 
Completed 
Degree (s) 
or D Not Applicable Resident? 1:81 yes Dno (if no) Citizenship 
Applicant is: 
Current 
Program 
MD 
1:81 current resident 
D current fellow 
D current post-doc 
Dother 
Professional Title (ex: ID Fellow) 
Neurosurgery/Global Health 
Resident 
Department/Division 
Surgery/Neurosurgery & 
Hubert Yeargan Center for 
Global Health 
Institution 
Duke Universityr 
Partnering US Institution (please write N.A. if not applicable) 
Hubert Yeargan Center for Global Health Duke University 
Department/Division Institution 
Name of Responsible Administrator: 
Name of Responsible Faculty (if different): 
Address: 
Street Address Aparlment!Unit # 
City State 
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Overseas 
I Institution 
Department/Division Institution 
! • ·'me of Responsible Administrator: 
[ . "me of Responsible Faculty (if different): 
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Phone 
Street Address A artment!Unit # 
State ZIP Code 
E-mail Address: 
' Name 
I am proposing to work at a Non-Pre-Approved ICRF site and have included a site application* 
*Only US citizens and permanent residents can propose to work at a non-pre-approved ICRF 
site. Others MUST apply with a pre-approved ICRF site. 
no 
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Proiect Title & Abstract 
DO NOT EXCEED 81 letters and spaces for title and 250 WORDS for abstract. 
Access to Care Barriers for N euro-oncology Patients in Western Kenya 
Sub-Saharan Africa contains over ten percent of the world's population, almost one-fourth of the global disease 
burden, but only three percent of global healthcare workers. These problems are exemplified in Kenya. Moi 
Teaching and Referral Hospital is a national hospital in Western Kenya. The catchment area for the sole 
neurosurgeon at Moi University is estimated to contain approximately 20 million people. No research has been 
published regarding how patients reach tertiary care centers in Kenya or how long they have had symptoms prior 
to presentation. Compared with acute disease treated by neurosurgeons, patients with a neuro-oncologic 
diagnosis' most often present in clinic. Further, there appears to be no published data on access to neuro-
oncology care in Kenya, delays in diagnosis possibly lead to more advanced stages at the time of diagnosis and 
potentially worse outcomes. We propose to describe the barriers to access of care for patients within this group. 
We hypothesize that differences will be found by age, gender, education level, financial resources, and location of 
a patient's residence in the ability for a patient to have timely access to neurosurgical oncology care in Western 
Kenya. We aim to determine what types of health care providers, if any, patients have seen prior to presenting to 
the neurosurgeon. Assessing the barriers experienced by neuro-oncology patients in reaching the only national 
hospital in Western Kenya will help us design programs to intervene and reduce the barriers experienced by 
patients. 
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Institution: Duke 
Overseas Site- based Mentor (may or may not be the same as the overseas faculty member on previous page) 
Name: Florentius MD Moi Co-Mentor 
Phone: 
Other Mentor(s) 
Name: 
Health 
Name: 
Phone: 
Email: 
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Applicant Name Stephen Parker 
RESEARCH PLAN 
DO NOT EXCEED 2,500 WORDS (Longer proposals will be truncated at 2500 words and reviewed as such) 
Background and Significance 
Access to Care in Kenya 
Page 4 
Most of sub-Saharan Africa patients live in an extreme rural community with fewer resources 
and further distances to hospitals/clinics than rural areas of developed countries, leading to these 
areas being severely disadvantaged for health and survival indicators.? Those with limited 
financial resources are even more vulnerable as deteriorating infrastructure in addition to 
unavailable or unaffordable transport decreases the chances for the poor to reach adequate 
medical facilities. The WHO has recommended that there should be at least 10 physicians per 
I 00,000 people; however, many countries in sub-Saharan Africa have most districts with less 
than 2 physicians per 100,000 people.4 Barriers to medical care access as well as the inequalities 
in the burden of disease have recently become a prominent concern for many countries in sub-
Saharan Africa.3 It is difficult to apply much of the work that has been done in developed 
countries into developing nations because of the different challenges faced in the developing 
world. Effective planning, interventions, and decision-making in an attempt to reduce barriers to 
medical care access should be based on evidence, not on guesswork. However, currently no 
good evidence exists to help policy makers make these difficult decisions. Kenya is 
representative of many countries within sub-Saharan Africa. Kenya is a vast country of over 580 
thousand square kilometers with a population of over 39 million people, over half of whom are 
between the ages of 15-64.8 We do not fully know what the current barriers that patients face in 
an attempt to access healthcare in Kenya and to what extent these barriers cause decreased access 
to medical care. Currently, there are two national referral hospitals within Kenya. Kenyatta 
National Hospital primarily serves the capital city of Nairobi and its surrounding area. The 
second hospital is Moi Teaching and Referral Hospital located in the city ofEldoret in the Rift 
Valley Provence.2 The hospital serves all of Western Kenya which is more rural and not as 
developed as Nairobi, thus the hospital serves many patients over a larger land area. 
Neurosurgery and Neuro-oncology Care in Kenya 
Neurosurgery throughout Africa has been improving over the past two decades. It is 
estimated that the continent now has 565 neurosurgeons currently practicing; however, most of 
these surgeons are practicing in the northern countries bordering the Mediterranean Ocean such 
as Morocco and Egypt or in South Africa. In Kenya, there are a few neurosurgeons practicing 
within Nairobi; however, only one neurosurgeon serves Western Kenya in the national health 
system while working at Moi University Teaching and Referral Hospital. The catchment area 
for the sole neurosurgeon within the public health system in Western Kenya is estimated to be 
approximately 1 neurosurgeon to 20 million people.5 Evaluating and addressing barriers to 
neurosurgical care is an important step in improving quality healthcare in Western Kenya as well 
as aiding in the retention of the only neurosurgeon in Western Kenya. Over the past few years 
the neurosurgeon at Moi University estimates that approximately one-third of his clinic patients 
present to him with a neuro-oncologic diagnosis. There appears to be no published data on 
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access to neuro-oncology care in Kenya and more specifically the less developed Western 
Kenya. There is extreme interest at Moi University Hospital in determining where neuro-
oncology patients are coming from, who they are, and if many patients are not finding their way 
to Moi Teaching and Referral Hospital. 
Research Environment at Moi University 
Indiana University School of Medicine and Moi University School of Medicine agreed to 
partner for the development of health care leaders for both the U.S. and Africa in 1989. This 
partnership helped provide outstanding training to future generations of health care providers. IU 
and Moi created one of Africa's first, largest, and effective HIV I AIDS control systems. The 
Indiana-Kenya Partnership provided a base to grow clinical care and research which led to the 
creation of the American/Sub-Saharan African Network of Training and Education (ASANTE) 
Consortium. The consortium is in a great position to assess and provide understanding of issues 
facing access to healthcare for patients of Western Kenya and share the information among 
network participants in order to reduce the burden of health disparities and implement programs 
aimed to remove barriers to health care and improve the current and future lives of East Africans. 
Duke University's Commitment to Global Health 
In 2004 the creation of the Rubert-Yeargan Center for Global Health signaled the value 
placed on formal bilateral international experiential education by Duke University. The Rubert-
Yeargan Center works with its international colleagues in human and infrastructure development 
to help reduce the burden of disease and health disparities around the globe. One of my co-
mentors for the project, G. Ralph Corey, MD, is Professor of Medicine and Infectious Diseases, 
Director of the Hubert Yeargan Center for Global Health, Gary Hock Distinguished Professor of 
Global Health and Director oflnfectious Diseases Research at DCRI. He previously served as 
the Program Director of the Internal Medicine Residency Training Program at Duke. He has 
supervised close to one thousand medical residents over the past twenty years and is instrumental 
in helping to establish research objectives for the Duke Global Health Residents. 
Another of my co-mentors for the project, Michael M. Haglund, MD, PhD, is Professor of 
Surgery and Neurobiology, Director of Surgical Epilepsy, and Program Director for the 
Neurosurgery Residency Training Program at Duke. He has been instrumental in developing the 
Duke Global Health Placement of Life-Changing Usable Surplus (PLUS) program. He also has 
been the driving force behind the creation of a Neurosurgery Residency Training Program in 
affiliation with Mulago University in Kampala, Uganda. He has a strong clinical and research 
interest for the intersection of neurosurgery, neurosurgery capacity building, and global health. 
The ASANTE research effort will be able to share that expertise with colleagues at Moi 
University with an onsite investigator from Duke, weekly conference calls, and clinical 
workshops. 
Specific Aim #I 
To identify and describe barriers to access for neurosurgical oncology care in Western Kenya. 
Hypothesis #I 
39 
Differences will be found by age, gender, education level, financial resources, and location of a 
patient's residence in the ability for a patient to access neurosurgical oncology care in Western 
Kenya. 
Specific Aim #2 
To identity and describe how neuro-oncology patients are referred and how long they take to 
reach a tertiary care referral center in Western Kenya. 
Hypothesis #2 
Time to neurosurgical care will be longer for patients who first present to traditional healers or 
non-professional healthcare workers compared with those who present initially to nurses or 
physicians. 
Specific Aim #3 
To describe specific characteristics and presenting symptoms for neuro-oncologic patients and 
create a database of the patients presenting to a tertiary care center in Western Kenya. 
Design and Outcomes 
Sample population: All patients ages > 18 years and older being seen in the Eldoret Neurosurgery 
clinic with a presumed neuro-oncologic diagnosis will be eligible for participation. 
Prior to July 2011, the principle investigator, Dr. Stephen Parker (SP) and a Kenyan research 
assistant will develop a personal interview questiounaire in English then will be subsequently 
translated into Kiswahili (the most common language spoken in Kenya). Beginning in August 
2011 Dr. Parker will spend one year at Moi University performing this two phase protocol. To 
assure appropriate translation, Dr. Parker and a research assistant will first give the interview 
questionnaire to 1-2 focus groups consisting of 5-6 individuals who speak Swahili as their 
primary language within Eldoret, Kenya. Questions will be revised and reordered as necessary 
based on focus group feedback. Over the next 2 months we will visit villages in the catchment 
area for Moi University Teaching and Referral Hospital and hold focus groups discussing the 
perceptions of neuro-oncologic illnesses and issues regarding regional variations for access to 
neurosurgical care. These focus groups will be recorded and analyzed to identity any other 
themes which should be addressed in the personal interview questiounaire. Fallowing 
completion of the focus groups, the personal interview questionnaire will be finalized and 
prepared for administration. 
Over the following 7 months Dr. Parker and a research assistant will obtain demographic, 
anthropomorphic, historical, and imaging characteristics for patients presenting to the 
neurosurgical clinic with a neuro-oncologic diagnosis. These data will be collected during a 
clinic visit or within 3 months if the patient is unable to complete the interview on the initial 
visit. The demographic, anthropomorphic, and historical data will be used to address the 
questions surrounding how patients present for neuro-oncologic care; however, all of the data, 
including imaging characteristics, will be used to help create a database for use in future 
epidemiology and outcome based studies. All neuro-oncologic diagnosis will be confirmed by 
either CT or MRl imaging. SP will review all radiographic imaging and neurologic physical 
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examinations. Nurses, residents and medical students will be trained in performing neurologic 
physical examinations via weekly didactic and practical experiences. Only the native Kiswahili 
speaking research nurse and research assistants will administer the personal interview 
questionnaire which will be completed by the participant in a separate interview room at their 
convemence. 
Interventions and Duration 
The survey will be developed in an iterative manner over the first 3 months of the project. The 
next phase will initiate the data collection and will allow us to obtain quantitative data. 
Participants will spend, on average, two more hours in the clinic on the day they are enrolled in 
this pilot. Enrollment will continue for 7 months or until an adequate sample size have been 
achieved. 
Sample Size and Population 
The target population for the analysis of patients with neuro-oncologic disease includes patients 
in the Neurosurgery clinic at Eldoret. Inclusion criteria: Age >= 18 years and a diagnosis or 
presumed neuro-oncologic diagnosis. Kenyan patients younger than 18 years are more likely to 
be dependants and thus have the potential to rely more heavily on guardians to reach a tertiary 
care referral center. Sample Size Estimate: It has been estimated that approximately 3-5 patients 
with a new neuro-oncologic diagnosis present to the neurosurgery clinic at Moi University 
Teaching and Referral Hospital per week. Over the course of seven months, we expect to enroll 
over 75 neuro-oncologic disease patients. 
Recruitment and Consent Process 
Eligible patients will be identified by clinical officers seeing patients in clinic. Patients will be 
referred to the research assistant at the discretion of their clinician. The research assistant will 
contact the patient in order to obtain consent to participate in the study. Informed consent is 
obtained in Kiswahili using forms at the appropriate reading level. The research assistant will be 
primarily responsible for patient enrollment and consent thereby limiting the need for translation. 
When translation is required, we will utilize Moi translators and nurses who are not part of the 
patient's primary care team. We will avoid using clinicians who have direct responsibility of 
each person's care to translate in an effort to limit bias and coercion. 
Statistical Methodology 
The data from the survey will be analyzed in a systematic manner. We will evaluate the overall 
patient characteristics focusing on length of time to neurosurgical oncology care as our outcome 
variable of interest. We will compare the prevalence ofthe most common variables thought to 
influence access to care. The baseline characteristics of the patient population will be evaluated 
in a univariate analysis and displayed as means and standard deviations for continuous variables 
and prevalence (percentages) for categorical variables. Bivariate analysis will then be performed 
comparing length of time to neurosurgical oncology care with categorical variables using a 
student's t-test and using simple linear regression for continuous variables. Finally multivariate 
regression will then be performed. 
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Conclusion 
Despite the high disease burden in Africa, indentitying and understanding barriers to care for patients take 
presenting to national referral hospitals is an important research goal. Assessing the barriers experienced 
by neuro-oncology patients in reaching the only national hospital in Western Kenya will not only help us 
design programs to potentially intervene and reduce the barriers experienced by those patients, but also to 
gain insight into the pathways patients took in reaching this tertiary care center. We will also be able to 
evaluate who are the patients that present to the tertiary care center and whether there are groups of people 
who have even less access than those who were able to navigate the barriers and arrive at Moi Teaching and 
Referral Hospital for care. Understanding these barriers to access of care will help us design future 
programs to intervene and reduce the barriers experienced by patients. In Drs. Haglund, Koech, Corey, and 
Parker we have brought together a team that is ideally suited to perform this analysis. 
Applicant Name Stephen Parker Page 9 
CAREER STATEMENT 
DO NOT EXCEED 500 WORDS 
My career mission is to become a clinical researcher in the epidemiology and treatment of 
neurosurgical diseases in the developing world in addition to being an educator and teacher for 
medical students and neurosurgical residents in East Africa, thereby improving the health of the 
disadvantaged by increasing the understanding and neurosurgical capabilities in the developing 
world. My earliest exposures to global medicine were during medical school and residency 
where I have served as a student, research assistant, global health resident, and neurosurgeon in 
Tanzania, Uganda, and Kenya. The culmination of my initial experiences have led to my 
involvement in helping to develop and shape the Duke In Uganda program which has recently 
begun the first neurosurgery residency program in Uganda. Moved by the large burden of both 
acute and chronic neurosurgical illnesses I have encountered in East Africa I decided to pursue a 
global health residency in addition to my neurosurgery training. Through my experiences in 
Tanzania, Uganda, and Kenya I have learned the importance of balancing the perceived needs of 
a developing country hospital with the stated needs, became adept at consensus-building, and 
worked within a hospital leadership structure vastly different from my own. Looking ahead, I 
have realized the need for clinical interactions to be coupled with regionally-relevant clinical 
research in collaboration with researchers from the developing areas in order to improve the 
healthcare provided to patients. 
Hence, during my training, I have endeavored to develop the essential skills necessary to create a 
foundation for success in these clinical research endeavors. I was accepted into the competitive 
Global Health Residency Program at Duke University and am currently completing a Masters 
degree in Public Health at the Gillings School of Global Public Health and the University of 
North Carolina- Chapel Hill. Through the MPH program I have obtained a strong background 
in epidemiology, biostatistics, and studied the principles of international health. As a 
neurosurgery resident I have worked closely with Dr. Michael Haglund and Dr. Ali Zomorodi in 
developing the Duke In Uganda Neurosurgery Program as well as helping to analyze objective 
data for the work started in Kampala for which the manuscript is currently being readied for 
submission. These overall efforts during my time at Duke University have served to solidity the 
basic skills necessary for me to be a successful clinical researcher. 
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' I 0 years, I envision myself in a developing country building neurosurgical capacity and systems for 
Jling with regional neurosurgical issues and leading the US global health neurosurgical initiatives as a 
member of a U.S. University. Whereas I have experience the clinical aspects of global neurosurgical 
clinical care, my exposure has lacked formalized oversight in international clinical research. The Fogarty 
International Clinical Research Fellowship will allow me to gain unique perspective within my field of 
interest, develop in-country professional relationships and build a foundation for a career in treating patients 
with neurosurgical illnesses in resource-limited parts of the world. 
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DO NOT EXCEED 1 PAGE 
Year I 
• Directly oversee the efforts ofthis protocol by being on-the-ground in Kenya and 
collecting most of the clinical data personally. 
• Mentor aspiring Kenyan clinical researchers and facilitate portions of a clinical research 
training curriculum. 
• Experience firsthand the features of conducting domestic and international clinical trials 
and outcomes studies including activities such as protocol development, study operations, 
continuing medical education curricula development, clinical events adjudication, as well as 
operational functions such as project and data management, site management, and utilization of 
information technology specific to multi-center clinical research studies. 
• Drafting manuscripts from data and analyses from Moi 
Please refer to the Request for Applications to see included Mechanisms of Support. The following budget reflects ALL 
estimated research and training costs required for completion of your proposed project. Use the column labeled 
"Disc/research funds" to indicate how you plan to spend the $15,000 allotted for these purposes. Please use the column 
labeled "Other Costs" to indicate other funding necessary for the completion of your project. 
Insert primary institution (U.S. unless none available) here 
Only report items Estimated Cost Disc/research funds to be used Source Covering 
below if needed (not to exceed $15Kl Difference 
Laptop 1,500 1,500 
Software 800 800 
Equipment 0 0 
Supplies 3,000 3,000 
Data Analysis 0 0 0 
Language Training 1,500 1,500 
Other: License 1500 1500 
Imal!inl! 5000 5000 
Non-US applicants must propose a stipend that is fair and equitable within their home institution 
and professional/eve/ (full-time). Documentation must be provided proving that the proposed 
stipend level fits these requirements. 
Proposed Stipend (non-US Applicants only): 
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Budget Justification 
Please discuss the items above, including details on additional sources covering the difference between estimated costs 
and items covered by discretionary/research funds. 
One laptop will be necessary for data storage, statistical analyses and electronic communication with my 
mentors while I am overseas. Necessary software includes the STAT A statistical package, Microsoft Office 
and Adobe Acrobat Professional; the latter two programs for manuscript/presentation preparation and intake 
form creation, respectively. I am also requesting research funds for non-medical supplies (DVD storage for 
images, paper, mailing supplies, printer toner) through. A Kiswahili language course will allow me to 
increase my basic Kiswahili knowledge and will directly improve the interaction with Kiswahili speaking 
collaborators and in the running of the focus groups. 'Other' fees include medical license and registration 
fees will which will allow me to take part in clinical research activities at Moi University. 
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